BENEFITING: PIN DOWN BLADDER CANCER
EVENT DATE: Apr 18, 2015
Pin Down Bladder Cancer is dedicated to increasing public awareness of bladder cancer through the charitable, educational and scientific means and raising funds to support programs and organizations that conduct and/or promote bladder cancer research, diagnosis and treatment. In particular, Pin Down Bladder Cancer benefits Memorial Sloan Kettering Cancer Center’s Bladder Cancer Translational Science Program, which focuses on the development of early detection strategies to improve more timely diagnoses and a molecular characterization effort to identify critical pathways driving the growth of bladder cancer cells in order to develop new treatment methods. The funds from this campaign will go directly into the hands of world class scientists that rapidly provide the advances needed for this disease.
Bladder cancer is the sixth most common cancer in the U.S. with approximately 75,000 new cases diagnosed per year, 15,000 deaths per year and 600,000 people living with the disease. Due to its high recurrence rate of 50-80%, bladder cancer requires life-long surveillance and care, making it the most expensive cancer to treat on a per patient basis with an estimated $4 billion spent annually. Despite its prevalence, bladder cancer is severely underfunded versus other common cancer types, only ranking 21st on the list of cancers funded by the National Cancer Institute.